Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

Subjects:

Summary of non-randomized studies. by Solima Sabeel (9545738)

Subjects:

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Participant characteristics. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. by Miki Kashiwagi (21439684)

CFSE staining of CD8+ T-cells for proliferation assessment. by Eiman Abdo (20642254)

Average days to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

“…Larger PIs (>4 cm²) showed greater reductions, with time to improvement decreasing by 35.5 days (34.7%, p < 0.001). …”

Densities of pAkt/tAkt bands from Western blots were quantified. by Tucker Hopkins (20790529)

Male flies with a mixed background have not responded to high temperature-mediated body fat loss. by Tucker Hopkins (20790529)

Characteristics of HACE respondents by year. by David Henderson (4612354)

“…</p><p>Results</p><p>Overall patient satisfaction with general practice declined significantly over the 10 years, with mean positive scores dropping from 90.1% in 2011/12 to 70.5% in 2021/22. …”

Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

Effect of CD8+ T-cells coculture and CM on hypoxic and normoxic PANC-1 cells. by Eiman Abdo (20642254)

Details of the GWAS data in this study. by Jing Wang (6206297)

“…</p><p>Results</p><p>This study shows that increases of anti-H. pylori IgG seropositivity was significantly associated with an increased risk of CHD (OR=1.003, 95% CI:1.0001.006, P = 0.048) and increases in peak insulin response (β = 0.214, 95% CI: 0.025–0.403, P = 0.026), decrease in total free cholesterol levels (β = ‒0.031, 95% CI: ‒0.061 to ‒0.000, P = 0.045), decreased waist circumference (β = ‒0.073, 95% CI: ‒0.138 to ‒0.008, P = 0.027) and waist-to-hip ratio (β = ‒0.069, 95% CI: ‒0.136 to ‒0.002, P = 0.044). …”